Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Observation on effect of peg interferon lphaa-2a treating lamivudine resistant chronic hepatitis B].

Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology - 1 Jun 2010

Bai Hong-lian, Luo Hong-tao, Ye Yi-nong, Long Hui, Zhong Rui-xing

Abstract excerpt

OBJECTIVE: To observe the efficacy and safety of PEG-interferon alpha-2a (PEG-IFNalpha-2a) treatment on lamivudine (LAM)-resistant chronic hepatitis B (CHB) patients. METHODS: Eighty-one patients with lamivudine-resistant HBeAg (+) chronic hepatitis B patients were enrolled and divided into PEG-IFNalpha-2a treatment group (40 cases) and adefovir dipivoxil (ADV) control group (41 cases). Two groups were combined...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Interferons

Share to Lamivudine

Share to Organophosphonates

Share to Polyethylene Glycols

Source

Identifiers

PMID: 21186536

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Observation on effect of peg interferon lphaa-2a treating lamivudine resistant chronic hepatitis B].PMID 21186536Read ↗

[Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].Semantic proximity Read ↗

[Therapeutic effect of antiviral regimens for chronic hepatitis B refractory to lamivudine plus adefovir].Semantic proximity Read ↗

[Clinical efficacy of various antiviral-based strategies to treat chronic hepatitis patients with positivity for hepatitis B e antigen and rtN236T mutation].Semantic proximity Read ↗

[Interferon in hepatitis B].Semantic proximity Read ↗

[A clinical study of adefovir dipivoxil, made in China, for treatment of hepatitis B e antigen-positive patients with chronic hepatitis B].Semantic proximity Read ↗

[Virological response of chronic hepatitis C management with peg-interferon alpha-2b and ribavirin].Semantic proximity Read ↗

[Efficacy of the 96-week adefovir dipivoxil therapy in patients with chronic hepatitis B].Semantic proximity Read ↗

[Relationship between B virus hepatitis genotypes and therapeutic efficacy in early treatment for chronic hepatitis B by using lamivudine].Semantic proximity Read ↗

[Clinical efficacy of lamivudine in the treatment of chronic hepatitis B].Semantic proximity Read ↗

[Evaluation of Chai Shao Liu Jun Tang for the treatment of chronic hepatitis B].Semantic proximity Read ↗

Two-year observation of the clinical efficacy in treating chronic hepatitis B Patients with Ganxian recipe and lamivudine.Semantic proximity Read ↗

Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.